Aviva
TNDM icon

Aviva’s Tandem Diabetes Care TNDM Stock Holding History

Aviva’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,361
Closed -$301K – 881
2024
Q4 		$301K Hold
8,361
– – ﹤0.01% 843
2024
Q3 		$355K Sell
8,361
-2,600
-24% -$110K ﹤0.01% 849
2024
Q2 		$442K Hold
10,961
– – ﹤0.01% 842
2024
Q1 		$388K Buy
+10,961
New +$294K ﹤0.01% 902
2021
Q2 		– Sell
-14,138
Closed -$1.25M – 973
2021
Q1 		$1.25M Buy
14,138
+2,513
+22% +$234K 0.01% 777
2020
Q4 		$1.11M Sell
11,625
-9,424
-45% -$971K 0.01% 847
2020
Q3 		$2.39M Sell
21,049
-4,960
-19% -$521K 0.01% 627
2020
Q2 		$2.57M Sell
26,009
-27,722
-52% -$2.21M 0.02% 563
2020
Q1 		$3.46M Buy
+53,731
New +$3.76M 0.03% 619

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aviva's TNDM Position: Q1 2025 in Review

Aviva sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 8,361 shares — an estimated $301K sold.

Aviva first reported a position in TNDM in Q1 2020 and held it in 9 quarters. The position peaked at $3.46M in Q1 2020. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • Aviva reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
  • Aviva sold 8,361 Tandem Diabetes Care shares in Q1 2025, an estimated $301K.
  • Aviva first reported a position in Tandem Diabetes Care in Q1 2020 and held it in 9 quarters.
  • Aviva's Tandem Diabetes Care position peaked at $3.46M in Q1 2020.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on Aviva's 13F filing for Q1 2025, filed 15 May 2025.